Smartwatch for sugar: could a CGM get people moving and stop diabetes before it starts?
NCT ID NCT07455435
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether wearing a continuous glucose monitor (CGM) can motivate people with prediabetes to be more physically active. Fifty adults with prediabetes will wear a CGM for 20 days and receive education on their blood sugar readings. The goal is to see if seeing real-time glucose data encourages more steps and helps stabilize blood sugar, potentially preventing type 2 diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
continuous glucose monitor (CGM) and physical activity education
What this could lead to
If it works, this could point toward a simple, wearable-based strategy to help people with prediabetes increase physical activity and lower their risk of developing type 2 diabetes.
What could go wrong
This is a small, early-stage study with only 50 participants and no control group, so results may not be generalizable. The intervention is short-term (20 days), so any benefits might not last.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••